Institutional Manager · CIK 0001819257
Patient Square Capital LP
Menlo Park, CA · File #028-22927
Latest AUM
$467.1M
Positions
28
Top-10 Concentration
77.5%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | ROIVANT SCIENCES LTD | ROIV | -4,313,953 | -$93.6M | +$82.0M |
| NEW | BEONE MEDICINES LTD | BEIGF | +69,312 | +$21.1M | $0 |
| ADD | MIRUM PHARMACEUTICALS INC | MIRM | +194,420 | +$15.4M | +$592,208 |
| NEW | TERNS PHARMACEUTICALS INC | TERN | +320,000 | +$12.9M | $0 |
| EXITED | CIDARA THERAPEUTICS INC | 171757206 | -121,000 | -$11.6M | $0 |
| NEW | COGENT BIOSCIENCES INC | COGT | +317,372 | +$11.3M | $0 |
| REDUCE | INSMED INC | INSM | -59,400 | -$10.3M | +$9.8M |
| ADD | ARGENX SE | ARGX | +10,500 | +$8.8M | +$1.6M |
| NEW | DBV TECHNOLOGIES S A | DBVTF | +359,050 | +$6.9M | $0 |
| NEW | XENON PHARMACEUTICALS INC | XENE | +136,500 | +$6.1M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202528 pos · $467.1M
- 13F HOLDINGS REPORTQ/E Sep 202524 pos · $373.9M
- 13F HOLDINGS REPORTQ/E Jun 202519 pos · $277.4M
- 13F HOLDINGS REPORTQ/E Mar 202519 pos · $241.7M
- 13F HOLDINGS REPORTQ/E Dec 202420 pos · $267.4M
- 13F HOLDINGS REPORTQ/E Sep 202411 pos · $269.4M
- 13F HOLDINGS REPORTQ/E Jun 20242 pos · $215.4M
- 13F HOLDINGS REPORTQ/E Mar 20242 pos · $234.8M
- 13F HOLDINGS REPORTQ/E Dec 20232 pos · $182.0M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ROIVANT SCIENCES LTD | ROIV | 8,166,047 | $177.2M | 37.93% |
| 2 | INSMED INC | INSM | 267,000 | $46.5M | 9.95% |
| 3 | MIRUM PHARMACEUTICALS INC | MIRM | 298,682 | $23.6M | 5.05% |
| 4 | ARGENX SE | ARGX | 26,000 | $21.9M | 4.68% |
| 5 | BEONE MEDICINES LTD | BEIGF | 69,312 | $21.1M | 4.51% |
| 6 | ABIVAX SA | AAVXF | 130,000 | $17.5M | 3.75% |
| 7 | PHARVARIS N V | PHVS | 542,696 | $15.1M | 3.22% |
| 8 | EYEPOINT INC | EYPT | 780,000 | $14.3M | 3.05% |
| 9 | TERNS PHARMACEUTICALS INC | TERN | 320,000 | $12.9M | 2.77% |
| 10 | CELCUITY INC | CELC | 120,000 | $12.0M | 2.56% |
| 11 | COGENT BIOSCIENCES INC | COGT | 317,372 | $11.3M | 2.41% |
| 12 | KYMERA THERAPEUTICS INC | KYMR | 139,000 | $10.8M | 2.32% |
| 13 | LIQUIDIA CORPORATION | LQDA | 227,000 | $7.8M | 1.68% |
| 14 | DBV TECHNOLOGIES S A | DBVTF | 359,050 | $6.9M | 1.47% |
| 15 | ALLOGENE THERAPEUTICS INC | ALLO | 4,963,756 | $6.8M | 1.46% |
| 16 | DIANTHUS THERAPEUTICS INC | DNTH | 150,000 | $6.2M | 1.32% |
| 17 | XENON PHARMACEUTICALS INC | XENE | 136,500 | $6.1M | 1.31% |
| 18 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 210,000 | $6.1M | 1.31% |
| 19 | OCULAR THERAPEUTIX INC | OCUL | 490,000 | $5.9M | 1.27% |
| 20 | DISC MEDICINE INC | IRON | 74,000 | $5.9M | 1.26% |